GHRP2

Type: Concept

As of November 2026, GHRP2 has been mentioned in one podcast episode on The Diary Of A CEO (Apr 2026). Discussed as a growth hormone releasing peptide.

Pralmorelin is a growth hormone secretagogue (GHS) used as a diagnostic agent that is marketed by Kaken Pharmaceutical in Japan in a single-dose formulation for the assessment of growth hormone deficiency (GHD).

GHRP2 at a glance
Mentioned in	1 episode on 1 podcast (as of November 2026)
First heard	Apr 2026 on The Diary Of A CEO
Field	Medicine

Who talks about GHRP2 on podcasts?

GHRP2 came up; the most recent mention was Apr 2026 on The Diary Of A CEO.

Peptide Expert: The Breakthrough Drugs Big Pharma and the FDA Buried! on The Diary Of A CEO (Apr 2026)

What is GHRP2 mentioned alongside?

GHRP2 is most often mentioned alongside Compounding pharmacy, Insulin and Obesity.

Mentioned together: Compounding pharmacy, Insulin, Obesity, BPC-157, TBI, Fertility, insulin sensitivity, Channing Tatum, FDA, GLP-1